Pharmacogenetic determinants of anti-cancer drug activity and toxicity. (Q34322733)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11479005%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

review article

1 reference

title

Pharmacogenetic determinants of anti-cancer drug activity and toxicity (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11479005%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11479005%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Filippo de Braud

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11479005%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Antonello Di Paolo

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11479005%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

5

M Del Tacca

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11479005%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

author name string

S Fogli

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11479005%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

publication date

1 August 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11479005%20AND%20SRC:MED&resulttype=core&format=json

Trends in Pharmacological Sciences

9 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11479005%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

volume

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11479005%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11479005%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

page(s)

420-426

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11479005%20AND%20SRC:MED&resulttype=core&format=json

Recent advances in research on multistage tumorigenesis

9 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901742-9

7 January 2021

Review of the efficacy of individualized chemotherapy selected by in vitro drug sensitivity testing for patients with cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901742-9

7 January 2021

Relation of cellular drug resistance to long-term clinical outcome in childhood acute lymphoblastic leukaemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901742-9

7 January 2021

Correlation of drug response with the ATP tumorchemosensitivity assay in primary FIGO stage III ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901742-9

7 January 2021

Pharmacogenetics and the practice of medicine

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901742-9

7 January 2021

Gene expression profiling, genetic networks, and cellular states: an integrating concept for tumorigenesis and drug discovery

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901742-9

7 January 2021

Pharmacogenomics: translating functional genomics into rational therapeutics

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901742-9

7 January 2021

The impact of genomics-based technologies on drug safety evaluation

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901742-9

7 January 2021

Phase I and pharmacokinetic study of farnesyl protein transferase inhibitor R115777 in advanced cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901742-9

7 January 2021

Epidermal growth factor receptor tyrosine kinase inhibitors as anticancer agents

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901742-9

7 January 2021

Disruption of p53 in human cancer cells alters the responses to therapeutic agents

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901742-9

7 January 2021

Spontaneous development of drug resistance: mismatch repair and p53 defects in resistance to cisplatin in human tumor cells

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901742-9

7 January 2021

p16INK4 expression is associated with the increased sensitivity of human non-small cell lung cancer cells to DNA topoisomerase I inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901742-9

7 January 2021

Apoptosis and cancer drug targeting

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901742-9

7 January 2021

Expression of apoptosis-related proteins is an independent determinant of patient prognosis in advanced ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901742-9

7 January 2021

Apoptosis and Bcl-2 expression in relation to age, tumor characteristics and prognosis in breast cancer. South-East Sweden Breast Cancer Group

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901742-9

7 January 2021

Deletion of the loop region of Bcl-2 completely blocks paclitaxel-induced apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901742-9

7 January 2021

Estrogen increases intracellular p26Bcl-2 to p21Bax ratios and inhibits taxol-induced apoptosis of human breast cancer MCF-7 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901742-9

7 January 2021

Induction of the death-promoting gene bax-alpha sensitizes cultured breast-cancer cells to drug-induced apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901742-9

7 January 2021

Induction of apoptosis in breast cancer cells MDA-MB-231 by genistein

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901742-9

7 January 2021

Ligands for peroxisome proliferator-activated receptorgamma and retinoic acid receptor inhibit growth and induce apoptosis of human breast cancer cells in vitro and in BNX mice

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901742-9

7 January 2021

Correlation between uracil and dihydrouracil plasma ratio, fluorouracil (5-FU) pharmacokinetic parameters, and tolerance in patients with advanced colorectal cancer: A potential interest for predicting 5-FU toxicity and determining optimal 5-FU dosa

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901742-9

7 January 2021

Genetic polymorphism of thiopurine methyltransferase and its clinical relevance for childhood acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901742-9

7 January 2021

Molecular diagnosis of thiopurine S-methyltransferase deficiency: genetic basis for azathioprine and mercaptopurine intolerance

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901742-9

7 January 2021

MTHFR gene polymorphism and severe toxicity during adjuvant treatment of early breast cancer with cyclophosphamide, methotrexate, and fluorouracil (CMF)

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901742-9

7 January 2021

Human UDP-glucuronosyltransferases: metabolism, expression, and disease

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901742-9

7 January 2021

Glutathione S-transferase genetic polymorphisms and individual sensitivity to the ototoxic effect of cisplatin.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901742-9

7 January 2021

Cytochrome P450 CYP3A in human renal cell cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901742-9

7 January 2021

Association of CYP3A4 genotype with treatment-related leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901742-9

7 January 2021

Kinetics of arylamine N-acetyltransferase in tissues from human breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901742-9

7 January 2021

10.1016/S0165-6147(00)01742-9

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11479005%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

1 reference